AEB-3103

N/A

Report date: 2025/01/26 19:08:46

Base Information

Drug NameAEB-3103
Drug Alias NameAECaseengineered and PEGylated human cysteine/cystine degrading enzyme (Aeglea BioTherapeutics)AEB-3103
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpyre Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpyre Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A